Alaunos Therapeutics Inc (TCRT)
2.39
+0.07
(+3.02%)
USD |
NASDAQ |
Nov 22, 16:00
2.355
-0.04
(-1.46%)
After-Hours: 20:00
Alaunos Therapeutics Price: 2.39 for Nov. 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 22, 2024 | 2.31 | 2.44 | 2.30 | 2.39 | 7132.00 |
Nov 21, 2024 | 2.15 | 2.34 | 2.15 | 2.32 | 15718.00 |
Nov 20, 2024 | 2.15 | 2.381 | 2.07 | 2.13 | 14381.00 |
Nov 19, 2024 | 2.14 | 2.273 | 2.11 | 2.11 | 7544.00 |
Nov 18, 2024 | 2.10 | 2.29 | 2.10 | 2.14 | 28881.00 |
Nov 15, 2024 | 2.411 | 2.411 | 2.074 | 2.09 | 22589.00 |
Nov 14, 2024 | 2.38 | 2.591 | 2.30 | 2.338 | 8555.00 |
Nov 13, 2024 | 2.41 | 2.86 | 2.40 | 2.40 | 36359.00 |
Nov 12, 2024 | 2.14 | 2.44 | 2.14 | 2.44 | 18465.00 |
Nov 11, 2024 | 1.95 | 2.15 | 1.95 | 2.10 | 41395.00 |
Nov 08, 2024 | 2.02 | 2.02 | 1.95 | 1.985 | 22335.00 |
Nov 07, 2024 | 2.08 | 2.12 | 2.018 | 2.02 | 6534.00 |
Nov 06, 2024 | 2.04 | 2.168 | 2.02 | 2.16 | 13459.00 |
Nov 05, 2024 | 2.01 | 2.069 | 2.01 | 2.04 | 6509.00 |
Nov 04, 2024 | 2.02 | 2.04 | 2.00 | 2.009 | 5255.00 |
Nov 01, 2024 | 2.04 | 2.04 | 2.02 | 2.04 | 9090.00 |
Oct 31, 2024 | 2.02 | 2.17 | 2.00 | 2.05 | 22501.00 |
Oct 30, 2024 | 2.06 | 2.09 | 2.020 | 2.020 | 6168.00 |
Oct 29, 2024 | 2.06 | 2.238 | 2.06 | 2.07 | 6269.00 |
Oct 28, 2024 | 2.19 | 2.205 | 2.00 | 2.059 | 24580.00 |
Oct 25, 2024 | 2.205 | 2.209 | 2.17 | 2.17 | 7937.00 |
Oct 24, 2024 | 2.35 | 2.35 | 2.16 | 2.20 | 9776.00 |
Oct 23, 2024 | 2.28 | 2.39 | 2.28 | 2.39 | 5937.00 |
Oct 22, 2024 | 2.16 | 2.369 | 2.16 | 2.27 | 5107.00 |
Oct 21, 2024 | 2.26 | 2.26 | 2.11 | 2.16 | 5572.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.985
Minimum
Nov 08 2024
840.00
Maximum
Feb 08 2021
232.23
Average
159.75
Median
Price Benchmarks
Microbot Medical Inc | 0.98 |
SELLAS Life Sciences Group Inc | 1.17 |
Galectin Therapeutics Inc | 2.78 |
Oragenics Inc | 0.274 |
Anavex Life Sciences Corp | 9.11 |
Price Related Metrics
Price to Book Value | 1.405 |
Earnings Yield | -310.0% |
Market Cap | 3.827M |